These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3923480)

  • 61. The structure of the amino terminal transforming segment of the p21 protein, Tyr4-Thr20 (with Asp12), by two-dimensional NMR.
    Longo PA; Broido MS; Chen J; Kung HF; Pincus MR
    Biochem Biophys Res Commun; 1988 Dec; 157(2):776-82. PubMed ID: 3144279
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Conformation of the transmembrane domain of the c-erbB-2 oncogene-encoded protein in its monomeric and dimeric states.
    Brandt-Rauf PW; Pincus MR; Monaco R
    J Protein Chem; 1995 Jan; 14(1):33-40. PubMed ID: 7779261
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Imprinting effects of proline containing dipeptides (proline-glycine, proline-leucine, proline-valine and their retro variants) in tetrahymena. Evolutionary conclusions.
    Csaba G; Kovács P
    Biosci Rep; 1997 Dec; 17(6):537-42. PubMed ID: 9561298
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A 1H-NMR study of the solution conformation of Icaria chemotactic peptide and its [Lys7] analog: effects on the physiological activity of a substitution of proline to lysine at position 7.
    Shimada I; Kato K; Saito K; Kitada C; Fujino M; Nakajima T; Arata Y
    Biochem Biophys Res Commun; 1990 Apr; 168(2):596-603. PubMed ID: 2110453
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Tertiary structures of gastrin-like tetrapeptides.
    Yamada T; Wako H; Saitô N; Isogai Y; Watari H
    Int J Pept Protein Res; 1976; 8(6):607-14. PubMed ID: 992944
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Predicting three-dimensional conformations of peptides constructed of only glycine, alanine, aspartic acid, and valine.
    Oda A; Fukuyoshi S
    Orig Life Evol Biosph; 2015 Jun; 45(1-2):183-93. PubMed ID: 25794830
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Conformational characteristics of polypeptides containing isolated L-proline residues with cis peptide bonds.
    Tonelli AE
    J Mol Biol; 1974 Jul; 86(3):627-35. PubMed ID: 4851145
    [No Abstract]   [Full Text] [Related]  

  • 68. The Biosynthesis of Protein. I. Uptake of glycine, serine, valine and lysine by the mammary gland of the rabbit.
    CAMPBELL PN; WORK TS
    Biochem J; 1952 Oct; 52(2):217-27. PubMed ID: 13018210
    [No Abstract]   [Full Text] [Related]  

  • 69. Mutations affecting the 12th and 61st amino acids of p21 protein result in decreased probability of beta-turn occurrence around the mutation positions: a prediction.
    Murakami M
    J Theor Biol; 1985 May; 114(2):193-8. PubMed ID: 3897719
    [No Abstract]   [Full Text] [Related]  

  • 70. [Synthetic polypeptides of the sequences (glycine-L-proline-L-serine)n and (glycine-L-serine-L-proline)].
    Heidemann E; Nill HW
    Z Naturforsch B; 1969 Jul; 24(7):843-51. PubMed ID: 4390038
    [No Abstract]   [Full Text] [Related]  

  • 71. A single-chain triple helical structure in synthetic polypeptides.
    Del Pra A; Tamburro AM; Scatturin A
    Experientia; 1975 Jan; 31(1):20-2. PubMed ID: 1112310
    [No Abstract]   [Full Text] [Related]  

  • 72. The gamma-turn as an independent conformational feature in solution.
    Khaled MA; Urry DW; Okamoto K
    Biochem Biophys Res Commun; 1976 Sep; 72(1):162-9. PubMed ID: 985463
    [No Abstract]   [Full Text] [Related]  

  • 73. A neutral polypeptide--calcium ion complex.
    Urry DW; Cunningham WD; Onishi T
    Biochim Biophys Acta; 1973 Apr; 292(3):853-7. PubMed ID: 4705458
    [No Abstract]   [Full Text] [Related]  

  • 74. Proline and glycine polymers and related proteins.
    McGavin S
    J Mol Biol; 1970 Feb; 47(3):611-3. PubMed ID: 5418173
    [No Abstract]   [Full Text] [Related]  

  • 75. A Comparative Analysis of Individual RAS Mutations in Cancer Biology.
    Muñoz-Maldonado C; Zimmer Y; Medová M
    Front Oncol; 2019; 9():1088. PubMed ID: 31681616
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Novel peptides from the RAS-p21 and p53 proteins for the treatment of cancer.
    Bowne WB; Michl J; Bluth MH; Zenilman ME; Pincus MR
    Cancer Ther; 2007; 5B():331-344. PubMed ID: 18007958
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Comparison of the average structures, from molecular dynamics, of complexes of GTPase activating protein (GAP) with oncogenic and wild-type ras-p21: identification of potential effector domains.
    Chen JM; Friedman FK; Brandt-Rauf PW; Pincus MR; Chie L
    J Protein Chem; 2002 Jul; 21(5):349-59. PubMed ID: 12206509
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Conformational effects of environmentally induced, cancer-related mutations in the p53 protein.
    Brandt-Rauf PW; Monaco R; Pincus MR
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9262-6. PubMed ID: 7937752
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Conformational effects of substituting amino acids for glutamine-61 on the central transforming region of the P21 proteins.
    Pincus MR; Brandt-Rauf PW; Carty RP; Lubowsky J; Avitable M; Gibson KD; Scheraga HA
    Proc Natl Acad Sci U S A; 1987 Dec; 84(23):8375-9. PubMed ID: 3120190
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Conformational effects of the substitution of Arg for Gly 13 in the ras oncogene-encoded P21 protein.
    Brandt-Rauf PW; Carty RP; Carucci J; Avitable M; Lubowsky J; Pincus MR
    J Protein Chem; 1988 Aug; 7(4):349-54. PubMed ID: 3076451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.